MX9205491A - Sintesis regioselectiva de agentes anti-inflamatorios de 1,5-diaril pirazol - Google Patents

Sintesis regioselectiva de agentes anti-inflamatorios de 1,5-diaril pirazol

Info

Publication number
MX9205491A
MX9205491A MX9205491A MX9205491A MX9205491A MX 9205491 A MX9205491 A MX 9205491A MX 9205491 A MX9205491 A MX 9205491A MX 9205491 A MX9205491 A MX 9205491A MX 9205491 A MX9205491 A MX 9205491A
Authority
MX
Mexico
Prior art keywords
diaril
pirazol
inflammatory agents
regioselective synthesis
regioselective
Prior art date
Application number
MX9205491A
Other languages
English (en)
Inventor
William V Murray
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MX9205491A publication Critical patent/MX9205491A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
MX9205491A 1991-09-26 1992-09-25 Sintesis regioselectiva de agentes anti-inflamatorios de 1,5-diaril pirazol MX9205491A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/766,611 US5117054A (en) 1991-09-26 1991-09-26 N-hydroxy, N-methyl propanamides

Publications (1)

Publication Number Publication Date
MX9205491A true MX9205491A (es) 1993-05-01

Family

ID=25076968

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205491A MX9205491A (es) 1991-09-26 1992-09-25 Sintesis regioselectiva de agentes anti-inflamatorios de 1,5-diaril pirazol

Country Status (16)

Country Link
US (1) US5117054A (es)
EP (1) EP0534800A3 (es)
JP (1) JPH05320137A (es)
KR (1) KR930005982A (es)
CN (1) CN1071161A (es)
AR (1) AR248396A1 (es)
AU (1) AU2358592A (es)
CA (1) CA2079045A1 (es)
FI (1) FI924307A (es)
HU (1) HUT62862A (es)
IL (1) IL103173A0 (es)
MX (1) MX9205491A (es)
NO (1) NO923728L (es)
TW (1) TW215085B (es)
ZA (1) ZA927393B (es)
ZW (1) ZW15092A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5117054A (en) * 1991-09-26 1992-05-26 Ortho Pharmaceutical Corporation N-hydroxy, N-methyl propanamides
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE19723631A1 (de) * 1997-06-05 1998-12-10 Consortium Elektrochem Ind Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
PT1413575E (pt) * 1999-08-03 2006-12-29 Ortho Mcneil Pharm Inc Processo para a preparação derivados de ácido (1, 5-diaril) pirazol-3-il]propanóico
JP2006522164A (ja) * 2003-04-03 2006-09-28 メルク エンド カムパニー インコーポレーテッド 代謝調節型グルタミン酸受容体−5のジアリール置換ピラゾール修飾因子

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218478A (en) * 1979-01-05 1980-08-19 Ruiko Oiwa Trichostatin as an antiprotozoal agent
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
US4681894A (en) * 1986-09-26 1987-07-21 Ortho Pharmaceutical Corporation Hydroxamic acids and esters
US4861798A (en) * 1986-12-29 1989-08-29 Bristol-Myers Company Lipoxygenase inhibitory compounds
US4898952A (en) * 1987-05-29 1990-02-06 Ortho Pharmaceutical Corporation Regioselective synthesis of a 1,5-disubstituted pyrazole
AU611437B2 (en) * 1987-05-29 1991-06-13 Ortho Pharmaceutical Corporation Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same
GB9005028D0 (en) * 1990-03-06 1990-05-02 Sandoz Ltd Improvements in or relating to organic compounds
US5117054A (en) * 1991-09-26 1992-05-26 Ortho Pharmaceutical Corporation N-hydroxy, N-methyl propanamides

Also Published As

Publication number Publication date
HUT62862A (en) 1993-06-28
HU9203078D0 (en) 1992-12-28
AR248396A1 (es) 1995-08-18
EP0534800A3 (en) 1993-06-16
NO923728D0 (no) 1992-09-25
CA2079045A1 (en) 1993-03-27
AU2358592A (en) 1993-04-01
IL103173A0 (en) 1993-02-21
CN1071161A (zh) 1993-04-21
TW215085B (es) 1993-10-21
US5117054A (en) 1992-05-26
KR930005982A (ko) 1993-04-20
JPH05320137A (ja) 1993-12-03
ZA927393B (en) 1994-03-25
FI924307A (fi) 1993-03-27
NO923728L (no) 1993-03-29
EP0534800A2 (en) 1993-03-31
FI924307A0 (fi) 1992-09-25
ZW15092A1 (en) 1994-06-15

Similar Documents

Publication Publication Date Title
DE69330129T2 (de) Synthese von 1,4,7-thiazacyclononan-derivaten
ATE151629T1 (de) Verbesserte shampoozusammensetzungen
NO924682L (no) Forbedret syntesefremgangsmaate
BR9101573A (pt) Composicao de xampu
KR920020863U (ko) 비누곽
LV10958A (lv) Aizvietotie 6- azaandrostenoni
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
TR28264A (tr) 2-alkoksi-2-imidazolin-5-one'larin fungisidal türevleri.
NO930926D0 (no) 2-oksokinolinderivater
MX9205491A (es) Sintesis regioselectiva de agentes anti-inflamatorios de 1,5-diaril pirazol
FR2672591B1 (fr) Synthese d'hydrogeno-perfluoroalcanes.
NO952485D0 (no) Antiinflammatorisk difluorpentapeptidderivat
ITMI912654A1 (it) Combinazione di estrusore-calandra
BR9202577A (pt) Emprego de solucoes
FI933290A (fi) 21-klorpregnanderivat
ITCT920024A0 (it) Denti-salva 1
KR970702873A (ko) 17β-시아노-3-에톡시-17α-하이드록시-6-메틸안드로스타-3,5,9-트리엔의 합성 방법(SYNTHESIS OF 17β-CYANO-3-ETHOXY-17α-HYDROXY-6-METHYLANDROSTA-3,5,9-TRIENE)
NO914028L (no) Syntese av 4-methylthiazol
KR920020864U (ko) 비누대
ITMI910434A1 (it) Procedimento migliorativo per la sintesi di n-fosfonometilglicina
ES1018409Y (es) "aspersor"
ITMI921785A0 (it) Procedimento per la sintesi dell'1-4-butandiolo
ES1022281Y (es) "taburete"
IT9047979A0 (it) Procedimento per la sintesi dell'alfa-tertiofene.
BR9200720A (pt) "reateste"